Take me to the text The following financial statements are taken from the records of Organo Inc. a) Use horizontal analysis techniques to compare the changes between 2019 and 2018 balance sheet items. Do not enter dollar signs or commas in the input boxes. Use the negative sign for negative values. Round all answers to 2 decimal places. Organo Inc. Balance Sheet As at September 30 2019 2018 % Change Current Assets Cash $328,400 $315,700 % Accounts Receivable $227,100 $187,800 % Merchandise Inventory $381,300 $409,500 % Short-Term Investments $127,600 $102,400 % Total Current Assets $1,064,400 $1,015,400 % Other Assets $195,800 $332,200 % Total Assets $1,260,200 $1,347,600 % Current Liabilities $271,700 $241,400 % Long-Term Debt $185,600 $148,800 % Total Liabilities $457,300 $390,200 % Shareholders' Equity $802,900 $957,400 % Total Liabilities and Equity $1,260,200 $1,347,600 % b) Perform a vertical analysis of the income statement for 2019, stating all income statement items as a percentage of net sales. Organo Inc. Income Statement For the Year Ended September 30 2019 Sales $716,000 Cost of Goods Sold $250,600 Gross Profit $465,400 Operating Expenses Advertising Expense $7.900 Bank Charges Expense $7,400 % Communication Expense $6,100 % Depreciation Expense $7,800 % Professional Fees Expense $7,000 % Rent Expense $5,900 % Repairs and Maintenance Expense $5,700 % Salaries and Wages Expense $55,300 Transportation Expense $6,200 Utilities Expense $6,200 Total Operating Expenses $115,500 Net Income $349,900